These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12133682)

  • 1. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Landolfi R; De Cristofaro R
    Lancet; 2002 Jul; 360(9328):257. PubMed ID: 12133682
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Meier JJ; Gallwitz B; Schmidt WE; Nauck MA
    Lancet; 2002 Jul; 360(9328):257. PubMed ID: 12133683
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
    Maree A; Fitzgerald D
    Haematologica; 2001 Nov; 86(11 Suppl 2):45-8. PubMed ID: 11926777
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials with glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes.
    Van de Werf F
    Thromb Haemost; 1997 Jul; 78(1):210-3. PubMed ID: 9198155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
    Harrington RA
    Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of platelet glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndrome and coronary intervention].
    Kakuta T; Kishi Y; Numano F
    Nihon Rinsho; 1998 Oct; 56(10):2630-4. PubMed ID: 9796330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety and economic efficiency of platelet IIb/IIIa receptor blockers in acute coronary syndromes without ST-segment elevation].
    Latour-Pérez J
    Rev Esp Cardiol; 2000 Aug; 53(8):1148-50. PubMed ID: 11032540
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical studies on glycoprotein IIb/IIIa receptor antagonist].
    Rasmussen LH; Husted SE; Clemmensen PM; Gøtzsche CO; Helqvist S; Kristensen SD; Pedersen KE; Rasmussen K; Rasmussen S
    Ugeskr Laeger; 2000 Oct; 162(44):5944-7. PubMed ID: 11094564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond aspirin: how glycoprotein inhibitors ease acute coronary syndromes.
    MacCallum EM; Hanlon SJ; Byrne KH
    Dimens Crit Care Nurs; 2000; 19(3):14-9. PubMed ID: 11998001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety.
    Vorchheimer DA; Fuster V
    Circulation; 1998 Feb; 97(4):312-4. PubMed ID: 9468202
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
    Jackson G
    Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glycoprotein IIB/IIIA receptor blockers as treatment of acute coronary syndromes and interventional cardiology].
    Abramovitch N; Halon DA; Flugelman Y; Lewis BS
    Harefuah; 1998 Jul; 135(1-2):41-7. PubMed ID: 10909532
    [No Abstract]   [Full Text] [Related]  

  • 13. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.
    Tricoci P; Peterson ED
    J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitors of platelet receptors GP IIB/IIIA: a new therapeutic class and its promise in the treatment of acute coronary syndromes].
    Yerna M; Legrand V; Kulbertus H
    Rev Med Liege; 1997 May; 52(5):329-35. PubMed ID: 9273634
    [No Abstract]   [Full Text] [Related]  

  • 15. [Abciximab (ReoPro) in the treatment of acute coronary syndromes].
    Rasmussen LH; Husted SE; Kassis E; Kastrup J; Kristensen SD; Pedersen KE; Grande P
    Ugeskr Laeger; 2001 Jan; 163(4):472-7. PubMed ID: 11218792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of the use of IIb/IIIa receptor blockers with or without the use of other anticoagulants.
    Ferguson JJ; Lau TK
    Semin Interv Cardiol; 1999 Jun; 4(2):97-102. PubMed ID: 10473879
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycoprotein IIb/IIIa inhibitors.
    Lincoff AM
    J Invasive Cardiol; 2004 Jul; 16(7 Suppl):11S-16S. PubMed ID: 23573566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet glycoprotein IIb/IIIa integrin blockade: recent clinical trials in interventional cardiology.
    Tcheng JE
    Thromb Haemost; 1997 Jul; 78(1):205-9. PubMed ID: 9198154
    [No Abstract]   [Full Text] [Related]  

  • 19. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
    Mukherjee D; Mahaffey KW; Moliterno DJ; Harrington RA; Yadav JS; Pieper KS; Gallup D; Dyke C; Roe MT; Berdan L; Lauer MS; Mänttäri M; White HD; Califf RM; Topol EJ
    Am Heart J; 2002 Dec; 144(6):995-1002. PubMed ID: 12486423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer therapeutic concept in antiplatelet aggregation inhibition--GPIIb-IIIa receptor antagonists.
    Malhotra S; Mishra NK; Sinha RS; Gupta B
    J Assoc Physicians India; 2000 Mar; 48(3):329-34. PubMed ID: 11229122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.